Article Details

FDA and the CMC Goalposts: CMC Should Accelerate, Not Curb, Gene Therapy Progress

Retrieved on: 2021-06-24 17:20:23

Tags for this article:

Click the tags to see associated articles and topics

FDA and the CMC Goalposts: CMC Should Accelerate, Not Curb, Gene Therapy Progress. View article details on hiswai:

Excerpt

(In fact, their origin can be traced to the 1980s, when monoclonal antibodies were first emerging as a cutting-edge field.) In a nutshell, FDA insists on ...

Article found on: www.lifescienceleader.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up